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ABSTRACT. Content of the 26-38-kD surfactant apoprotein (SP-A) was determined in lung homogenates from fetal (17-21 d gestation), postnatal (1-28 d of life), and adult male and female rats by a double sandwich ELISA. Expression of mRNA for SP-A as well as the hydrophobic apoproteins, SP-B and SP-C, were also determined in lung homogenates from fetal and adult rats of both sexes by Northern blot analysis. SP-A was undetectable in fetal Pulmonary surfactant is a complex aggregation of phospholipids and lung-specific apoproteins that functions to reduce surface tension in the alveolus and maintain alveolar stability at low lung volumes (1, 2) . Surfactant is composed of 80-90% phospholipids, 10% cholesterol, and 5-10% protein. The major functional component of surfactant phospholipids appears to be dipalmitoyl phosphatidylcholine (3) . Three families of lung-specific apoproteins have been described (4) . The most well characterized of these is a glycoprotein with a M, of 26-38 kD under reducing conditions (5) that has recently been designated SP-A (4). SP-A has been shown to play a role in the formation of tubular myelin in the presence of calcium ions (6) and in enhancing the adsorption of surface-active phospholipids to an air-liquid interface (7) . SP-A has also been shown to inhibit secretion of phosphatidylcholine in cultured adult rat alveolar type I1 cells and thus may be important in the regulation of surfactant secretion (8) (9) (10) . Two other very hydrophobic proteins are specifically associated with surfactant and have been designated SP-B and SP-C (4). SP-B has a M, of 18 kD under nonreducing conditions and a M, of 5-8 kD under reducing conditions (5) . SP-B is capable of enhancing the adsorption of surface-active phospholipids at an air-liquid interface in the presence of calcium ions. When combined with SP-A, this effect is further enhanced (1 I), SP-C has a M, of 5-8 kD under both reducing and nonreducing conditions (5) . SP-C may also play a role in enhancing adsorption of surface-active phospholipids at an air-liquid interface; however, its major functions remain to be defined.
There is a marked increase in lung synthesis and content of surfactant phospholipids in most mammals at the completion of' 85 to 90% of gestation (12) . Sex differences exist in the appearance of surfactant phospholipids in human amniotic fluid (1 3) and in fetal rat lung (14) . Recently, SP-A has been shown to markedly increase in human amniotic fluid (1 5 ) and in fetal rat lung (16) during the latter part of gestation. No information is available, however, concerning sex differences in the appearance of SP-A and SP-A mRNA in the fetal lung. Recently, in vitro translatable SP-A mRNA has been shown to decline in rabbit neonatal and adult lung (17, 18) and SP-A content has been shown to decline in neonatal rat lung (19) . However, no information is available concerning postnatal changes in lung SP-A content after the immediate neonatal period. Little information is available concerning appearance of SP-B and SP-C in the fetal lung; accordingly, no information exists regarding possible sex differences in expression of these hydrophobic apoproteins. In this report, we describe the ontogeny of SP-A in the fetal and postnatal male and female rat lung and the expression of mRNA's for SP-A, SP-B, and SP-C in the fetal male and female rat lung. For the ELISA, 0.1 mL rabbit antirat SP-A IgG fraction (0.1 pg/mL in 0.1 M NaHC03, pH 9.3) was incubated overnight at 22°C in wells of untreated microtiter plates (Dynatech Laboratories Inc., Alexandria, VA). The wells were then allowed to incubate at least 30 min with PBS without calcium or magnesium, pH 7.4 containing 1% (vol/vol) Triton X-100 (Sigma Chemical Co., St. Louis, MO) and 3% (w/v) BSA (Sigma) (3% BSA/l% Triton X-100/PBS). The wells were washed twice with 1 % Triton X-lOO/PBS, then 0.1 mL of purified rat SP-A standard (0-20 ng/mL in 5 mM Tris buffer) or various dilutions of sample lung homogenate were added to each well and allowed to incubate at 37°C for 90 min. The wells were washed three times with 3% BSA/I % Triton X-lOO/PBS, then 0.1 mL of rabbit anti-rat SP-A IgG fraction (20 /*g/mL in 3% BSA/l% Triton X-1001 PBS) conjugated with horseradish peroxidase (Boehringer Mannheim, Indianapolis, IN) was added to each well and allowed to incubate at 37°C for 90 min. After four washes with 1 % Triton X-IOO/PBS, 0. homogenized in 4 mL of 1 % Triton X-100/PBS using a Polytron (Brinkman Instruments, Westbury, NY). DNA was prepared from 0.1-0.2 ml of the lung homogenate by precipitation with 10% trichloracetic acid and extraction with methanol and absolute alcohol. DNA was then assayed by the fluorometric method of Setaro and Morley (20) .
Determination of lung protein.
Lung tissue was homogenized in 1% Triton X-100/PBS as described above. Protein content was then determined from 0.025-0.050 mL of lung homogenate by the bicinchoninic acid method of Smith et al. (21) .
Preparation of RNA and Northern blot analysis. Total RNA was extracted from lung tissue with 4 M guanidinium isothiocyanate, 0.5% N-laurylsarcosine, and 0.1 M P-mercaptoethanol in 25 mM sodium citrate buffer. The RNA was purified by centrifuging the lysate through a cushion of 5.7 M CsCl at 150 000 x g for 18 h at 22°C (22) . RNA was then size-fractionated by electrophoresis through a 1 .O% agarose gel under denaturing conditions and transferred to nitrocellulose or Nytran (both from Schleicher & Schuell, Keene, NH) by capillary action. Northern blots were prehybridized at 42°C for 2 h in 5x SSPE (I x SSPE is 0.1 5 M sodium chloride, 10 mM sodium phosphate, and 1 mM EDTA, pH 7.0), 0.1% SDS, 5X Denhardt's solution, 0.2 mg/ml salmon sperm DNA (Sigma), 50% formamide (International Biotechnologies Inc., New Haven, CT) and then hybridized with 5 x lo5 dpm/ml 32P-labeled specific rat cDNA probe in 5x SSPE, 5x Denhardt's solution, 0.2 mg/ml salmon sperm DNA, 10% dextran sulfate, 0.1 % SDS, and 50% formamide at 42°C for 16-24 h. 32P-labeled SP-A cDNA was prepared by random primer second strand synthesis (25) from a previously isolated rat cDNA for SP-A (23). Rat SP-B cDNA was isolated from a rat lung X gtiO cDNA library (kindly provided by Dr. F. Murad, Stanford University, Stanford, CA) by screening with a human SP-B cDNA clone (kindly provided by Dr. R. T. White, California Biotech Inc., Mountain View, CA) (24) . 32P-labeled SP-B cDNA was prepared from purified rat SP-B insert isolated on a low temperature melting agarose gel and labeled by random primer second strand synthesis (25) . Rat SP-C cDNA was isolated from the same rat lung cDNA library using a human SP-C cDNA clone (kindly provided by Dr. R. T. White) (26) . 32P-labeled SP-C cDNA was prepared from rat SP-C insert isolated on a low temperature melting agarose gel and labeled by random primer second strand synthesis (25) . Given the fact that all three inserts are of similar length and GC content, are of rat origin, and are radiolabeled by the same technique, then the efficiency of hybridization of all three probes should be nearly identical. After hybridization, Northern blots were washed four times for 30 min at 42°C in 400-ml portions of 2x SSC (I x SSC is 0.15 M sodium chloride and 15 mM trisodium citrate) plus 0.1 % SDS, followed by one 30-min wash at 55°C in 0 . 2~ SSC plus 0.1% SDS, and then a final wash for 5 min at 55°C in 0 . 2~ SSC. Northern blots were autoradiographed at -70°C using Kodak X-Omatic cassettes equipped with intensifying screens (Eastman Kodak, Rochester, NY). For reprobing, blots were heated to 85°C in 1% glycerol in water for 10 min (27) and then hybridized with another 32P-labeled specific probe under the hybridization conditions described above. Efficient removal of radiolabeled probe was monitored by autoradiography of washed blots for 24 h at -70°C. Electron microscopy. Fetal rat lung samples were prepared for transmission electron microscopic examination as previously described (28) . Briefly, fetal rat lung tissue was immersed in fixative containing 2% glutaraldehyde, 1 % paraformaldehyde, in a 0.1 M phosphate buffer. After 4 h tissue samples were transferred to a 1.5% osmium tetroxide in veronal acetate buffer and postfixed overnight. Specimens were then en bloc stained with 1.5% uranyl acetate in sodium maleate buffer, rapidly dehydrated with a graded series of acetone, transferred to propylene oxide, then infiltrated and embedded in a Luft's 3:7 epon resin (29) . Sections were stained with uranyl acetate and lead citrate (30) , and then examined in a Philips 400T electron microscope.
Statistics. Determinations of fetal lung SP-A, DNA, and protein content were performed on three to five litters per age for gestational ages 17-2 1 d. Male and female fetal lungs were pooled separately for each litter as described above. Determinations of postnatal and adult lung SP-A, DNA, and protein content were performed on four to seven animals per age. Values for lung SP-A content are expressed as mean (ng SP-A/pg DNA or pg SP-A/pg protein) f SE. Differences in SP-A content at different ages and sex differences in SP-A content at each age were compared by ANOVA. Inasmuch as there were only significant differences in SP-A content on the basis of age ( p < 0.001), differences in SP-A content at different ages were further analyzed by Ryan-Einot-Gabriel-Welsch multiple range test (31) with statistical significance accepted at p < 0.05. Statistical analyses were run on SAS software (SAS Institute Inc. Cary, NC).
RESULTS
Electron microscopy. The ultrastructural appearance of fetal lungs analyzed in this study was consistent with that described previously (32) . On gestational d 17 (glandular stage), the respiratory epithelium was characterized by undifferentiated tall columnar epithelial cells, some of which contained small accumulations of intracellular glycogen. There were no identifiable lamellar bodies (Fig. 1) . On gestational d 19 (canalicular stage), the respiratory epithelium was characterized by more cuboidalshaped epithelial cells, some of which now demonstrated morphological characteristics of type I1 cells (Fig. 2) . These early type I1 cells contained lamellar bodies and large accumulations of intracellular glycogen. Occasional lamellar whorls could be found in airway lumina. On gestational d 21 (terminal sac stage), the respiratory epithelium was characterized by a more flattened appearance with mature type I1 cells, type I cells, occasional undifferentiated cells, and close approximation to the capillary endothelium (Fig. 3) . These type I1 cells contained lamellar bodies and only small or nonexistent intracellular accumulations of glycogen. Lamellar whorls and tubular myelin could be found in airway lumina. Although quantitative morphometric analysis was not performed, there were no grossly apparent morphological sex differences noted on gestational d 17, 19, or 2 1. Fetal SP-A content directly correlated with mean fetal weight (r2 = 0.89). There were no statistically significant sex differences in SP-A content for any gestational age examined.
SP-A content on the day of birth was not significantly different from SP-A content on gestational d 21 (Fig. 4) . However, there was a significant decline in SP-A content when normalized to lung protein on postnatal d 2, 5, 7, and 14 when compared to SP-A content on gestational d 21 ( Consistent with recently reported results (33) , two species of SP-A mRNA were detected in the fetal rat lung during late gestation (Fig. 5) . Expression of the 1.6-and 0.9-kb species of SP-A mRNA was first detected in fetal lung on gestational d 18 and then the relative abundances of these two species increased proportionately until gestational d 2 1, but remained below adult levels. Expression of SP-B mRNA, as a 1.5-kb species, was also first detected in fetal lung on gestational d 18 and then increased in relative abundance to adult levels by gestational d 20 (Fig. 6 ).
Expression of SP-C mRNA, as a 0.8-kb species, was clearly detected in fetal lung on gestational d 17 and then increased in relative abundance to adult levels by gestational d 20-21 (Fig.  7 ). In the Northern blots shown (Figs. 5-7) no obvious sex differences were observed in the fetal expression of any of the apoprotein mRNA on d 17-1 8 of gestation. As noted above, these autoradiograms were intentionally overexposed to detect the earliest onset of expression, thus resulting in overexposing of the samples of later gestational ages. Shortening the exposure time on these blots, however, revealed that there were also no obvious sex differences on days 19-21 (data not shown). Shortening of exposure times also better demonstrated the comparison of relative abundance of the three apoprotein mRNA between late gestation fetuses and adult animals. Control preparations of RNA extracted from rat liver and kidney showed no hybridization with any of the cDNA probes used (Figs. 5-7 ).
DISCUSSION
In this study, we describe the ontogeny of SP-A and SP-A mRNA in the developing rat lung. We also describe for the first time the expression of mRNA for the hydrophobic surfactant apoproteins, SP-B and SP-C, in the developing rat lung during late gestation. The results show that SP-A and SP-A mRNA were not detected until type I1 cells appeared morphologically in the lung. Then SP-A and SP-A mRNA increased in parallel until term, but never reached levels seen in the adult lung. The results also show that fetal rat SP-A mRNA is expressed as two species of mRNA (1.6 and 0.9 kb) that appear to accumulate in near constant relative abundance until term. SP-B mRNA was detected as a 1.5-kb species at the time of morphologic appearance of type I1 cells; however, unlike SP-A mRNA, its relative abundance increased to adult levels before the end of gestation. In contrast to SP-A mRNA and SP-B mRNA, SP-C mRNA was clearly detected as a 0.8-kb species before the morphologic appearance of type I1 cells, and similar to SP-B mRNA, its relative abundance increased to adult levels before the end of gestation.
We were unable to demonstrate sex differences in SP-A content or in the expression of the three surfactant apoprotein mRNA during fetal lung maturation.
We also report in this study changes in lung SP-A content during postnatal lung development. In agreement with previous results, we observed an initial decline in SP-A content during the 1st wk of life (19) . After this immediate neonatal period there was a gradual increase in SP-A content beginning at the end of the 2nd wk of life, reaching adult levels after postnatal d 28. We were unable to demonstrate sex differences in SP-A content during postnatal lung maturation.
In agreement with our results, SP-A has recently been shown to markedly increase in human amniotic fluid (15) and in fetal rat lung (16) during late gestation. Our results show developmental changes in fetal lung SP-A content closely parallel changes in fetal expression of SP-A mRNA. Our results are in agreement with previous results which show that two species of mRNA (1.6 and 0.9 kb) encode adult rat SP-A (20) and that these two species of mRNA accumulate in relatively constant proportions during late gestation (33) . These two species of mRNA arise from differential polyadenylation of a single primary gene transcript and encode an identical final SP-A polypeptide (33) . The significance of the two species of rat SP-A mRNA awaits further elucidation.
Our results are also similar to the limited results available concerning the expression of mRNA for the hydrophobic surfactant apoproteins. Recently, the relative abundance of mRNA for the hydrophobic surfactant apoproteins has been shown to increase in human fetal lung from 16 to 24 wk gestation (34) . Furthermore, the same investigators showed that the relative abundance of both SP-B mRNA and SP-C mRNA increased rapidly in explant culture of human fetal lung, but the time sequence of this increase differed from changes in the relative abundance of SP-A mRNA, which increased somewhat later 172 SCHELLHASE ET AL. Ontogeny of SP-C mRNA in the developing rat lung. This is a representative Northern blot of total lung RNA isola~ed at different gestational ages from pooled fetal lung and probed with SP-C cDNA. Each lane was loaded with 10 pg RNA. This blot was intentionally overexposed to show that SP-C mRNA was clearly detectable as a 0.8-kb species on d 17. The relative abundance of SP-C mRNA then rapidly increased to adult levels by d 20-2 1. On this and other less exposed blots, there were no consistent differences between male and female pooled lungs isolated from the same litter. SP-C mRNA was not detected in liver or kidney. (34) . Our results show that not only does the accumulation of SP-B and SP-C mRNA differ from that of SP-A but also the onset of expression of SP-C mRNA appears to precede that of SP-A and SP-B. We thus speculate that the genes for the surfactant apoproteins may be differentially regulated.
The reasons for the differences in expression of the surfactant apoproteins during fetal lung maturation are unclear. The functional importance of these apoproteins, especially SP-B, in enhancing adsorption of surface-active phospholipids to an airliquid interface has recently been described (1 1, 39,40) . Previous investigations have shown that the surface activity of surfactant reaches near adult levels during late gestation (35, 36) . Our results show that the expression of mRNA for SP-B and SP-C are at adult levels during late gestation. These results correlate with observations from a number of investigators (1 1, 37-40) that SP-B and SP-C may be more functionally important proteins to the biophysical properties of surfactant than SP-A. Thus SP-B and SP-C may be better indices of lung maturation than SP-A.
Sex differences in the appearance of surfactant apoproteins in the developing fetal lung have not previously been investigated. An apparent female advantage in the developing fetal rat lung has been observed in lung epithelial cell proliferation (41) , in the proportion of epithelial cells containing lamellar inclusions during late gestation, and in the appearance of surfactant phospholipids (14) . A female advantage has also been observed in the appearance of surfactant phospholipids in human amniotic fluid (13) and in the incidence of respiratory distress syndrome in human premature infants after antenatal steroids (42) . One possibility for the lack of sex differences in the fetal expression of surfactant apoproteins observed in our study is that Northern blots are not sensitive enough to detect small changes in relative abundance of specific mRNA. However, using a sensitive ELISA, sex differences were also not detected in the fetal lung content of SP-A. Thus, on the basis of the observations in our study, the apparent female advantage in rat lung maturation during late gestation cannot be explained on the basis of sex differences in the expression of mRNA for surfactant apoproteins or in lung content of SP-A. The use of more accurate techniques to quantitate mRNA abundance may eventually show sex differences in the fetal expression of mRNA for the surfactant apoproteins. One such technique is RNA-RNA hybridization in solution (43) , which can easily detect differences of less than 10% in specific mRNA copy number per cell. Further, the development of ELISA techniques to quantitate the lung content of SP-B and SP-C may eventually show sex differences in the fetal appearance and accumulation of these hydrophobic apoproteins.
In addition to the changes during fetal rat lung maturation in surfactant apoproteins reported in our study, we report the changes in content of SP-A during rat postnatal lung maturation. The reasons for the initial decline in SP-A content during the 1 st wk of life are unclear. Postnatal rat lung development has been characterized by three phases (44) . During d 1 to 4 there is "lung expansion" with only small increases in total number of lung cells. During d 4 to approximately 13 there is "tissue proliferation" with significant increases in number of lung cells and alveoli. After day 13 there is "equilibrated growth" with slow increases in total number of lung cells, lung volume, and number of alveoli. The lung cell population changes significantly during the second phase (45) . There is a nearly 3-fold increase in fibroblasts, 2-fold increase in endothelial cells, and beginning on d 7 a 2-fold increase in type I1 cells. In addition, there is a significant increase in the number of alveoli and alveolar surface area. We speculate that the observed initial decline in SP-A content during the 1st wk of life may be due to the rapid proliferation of fibroblasts and endothelial cells, with little change in the number of type I1 cells. In this case, the DNA and protein contributed by nontype I1 cells would effectively decrease the amount of SP-A normalized on either a DNA or protein basis. Thus it may also be true that the observed increase in SP-A content beginning at the end of the 2nd postnatal wk may be related to the concurrent increase in number of type I1 cells and increasing number of alveoli. Changes in the rate of synthesis of SP-A by existing and new type I1 cells could present an alternative explanation for the changes we observed in SP-A content during postnatal lung maturation.
In summary, we have described the ontogeny of the surfactant apoproteins during fetal rat lung maturation and the ontogeny of SP-A during postnatal rat lung development. We have observed no sex differences in the fetal expression or appearance of surfactant apoproteins, or in postnatal changes in SP-A content. We speculate that the genes for the surfactant apoproteins may be differentially regulated, that the hydrophobic apoproteins SP-B and SP-C have an important effect on the increasing surface activity of surfactant during late gestation, and that the postnatal changes in SP-A content are related to changes in numbers and types of lung cells. A further understanding of the functional importance and regulation of the surfactant apoproteins during fetal and postnatal lung maturation may lead to additional strategies to prevent or treat infant respiratory distress syndrome and other neonatal lung disorders.
